Bi-213-DOTATOC
213Bi-DOTATOC is one alpha-labeled analogue of 90Y- and 177Lu-DOTATOC. This [...]
At-211-BC8-B10
211At-BC8-B10 is a radioimmunoconjugate containing the murine IgG1 anti-CD45 monoclonal [...]
Ac-225-DOTA-SP
225Ac-DOTA-SP (225Ac-Substance-P) is developed as local treatment for glioblastoma and [...]
Ra-223-Radium Dichloride
223Ra-Radium Dichloride (223Ra-Xofigo® previously known as 223Ra-Alpharadin), is a 223Ra [...]
At-211-MX35-F(ab’)-2
211At-MX35-F(ab’)2 is a radiolabeled antibody fragment developed and characterized [...]
At-211-81C6 mAb (Neuradiab)
211At-81C6-mAb (anti tenascin, human/mouse chimeric antibody) is a radiotherapeutic based [...]
Pb-212-DOTAMTATE
212Pb-DOTAMTATE (212Pb-AlphaMedix™) is a somatostatin analogue labeled with Lead-212 [...]
Bi-213-Lintuzumab (Bi-213 Bismab-A™)
213Bi-Lintuzumab (213Bi-Bismab-A™, 213Bi-CHX-A’’-DTPA-huM195) is an anti-CD33 humanized antibody huM195 labeled [...]
Ac-225-FPI-1434
225Ac-FPI-1434 (225Ac-FPX-01) is an alpha labeled antibody under development for [...]
Ac-225-Lintuzumab (Ac-225 Actimab-A™)
225Ac-Lintuzumab (225Ac-Actimab-A™, 225Ac-DOTA-huM195) is the new name of the lead [...]